Category: Healthcare

The global age-related vision dysfunction market reached an estimated valuation of USD 91 Billion in 2024 and is projected to grow significantly, reaching approximately USD 131 Billion by 2034.

The global AI-based clinical trials solution provider market is projected to witness substantial growth, with its market size expected to rise from USD 3.2 billion in 2024 to USD 9.7 billion by 2034, reflecting an impressive CAGR of 15.3% during the forecast period.

The global AIDS-related primary CNS lymphoma market size is anticipated to grow from USD 1,128 million in 2024 to USD 3,145 million by 2034, with a CAGR of 7.65% during the forecast period.

The global air ambulance services market is projected to grow significantly, with its valuation increasing from USD 6.2 billion in 2024 to USD 20.5 billion by 2034, reflecting an enhanced CAGR of 13.3% during the forecast period.

The global air fluidized therapy beds market is projected to grow from USD 654.5 million in 2024 to USD 1,236 million by 2034, with an improved CAGR of 6.7%.

The global airlift bioreactors market is projected to expand significantly, rising from USD 3.4 billion in 2024 to USD 7.9 billion by 2034, reflecting an impressive CAGR of 12.2% during the forecast period.

The global airotar handpiece market is poised for significant growth, with its value projected to increase from USD 2.08 billion in 2024 to USD 2.97 billion by 2034, reflecting a CAGR of 6.04% over the forecast period.

The global ambulatory surgical centers (ASCs) market is projected to grow at a revised CAGR of 5.5% from 2024 to 2034.

The global brain implants market was valued at USD 6.2 billion in 2026 and is projected to reach USD 13.7 billion by 2033, expanding at a CAGR of 11.9% during the forecast period.

In 2026, the antidiabetics market is estimated to be valued at USD 82.4 billion, with projections indicating a rise to USD 136.7 billion by 2033, reflecting a CAGR of 7.5% during the forecast period.